Date: Monday, October 5, 2026 [virtual training offered via Zoom]
Time: 11:30 am - 1:00 pm Pacific Time. (All of our virtual trainings are in Pacific Time. If you are unsure about the time zone differences, please use the Time Converter.)
Registration Deadline: Thursday, October 1, 2026 at 5:00 pm Pacific Time
Description: This webinar will highlight the clinical management of TB meningitis including use of standard versus high-dose rifampin. This webinar is jointly provided by the National Tuberculosis Coalition of America (NTCA), Curry International Tuberculosis Center (CITC), and Heartland National TB Center (HNTC). This lecture was first presented during the National Society of Tuberculosis Clinicians (NSTC) Professional Development Track at the 30th National TB Conference hosted by NTCA.
Target Audience: This training is intended for physicians, nurses, and other licensed medical and public health professionals who provide care to patients in treatment for active TB.
Credit: CMEs and Nursing CEs are not available for this webinar.
Cost: There is no fee for this training.
Objectives:
By the end of the training, participants will be able to:
- analyze emerging data on the use of high-dose rifampin and apply these findings to the clinical management of individuals with TB meningitis.
- discuss the role of host-directed therapies in the clinical management of individuals with TB meningitis.
Training Format: Virtual training includes lectures and Q&A/discussion.
Presenters:
Felicia Chow, MD, MAS
Professor, Neurology and Medicine (Infectious Diseases)
School of Medicine
University of California, San Francisco
San Francisco, CA
Barbara Seaworth, MD
Professor of Medicine (Infectious Diseases)
University of Texas Health Science Center at Tyler
Co-Medical Director
Heartland National TB Center
San Antonio, TX
Moderators:
Lisa Chen, MD
Medical Director/Principal Investigator
Curry International Tuberculosis Center
University of California, San Francisco
San Francisco, CA
Janice Louie, MD, MPH
NSTC President
National Tuberculosis Coalition of America
Medical Director
Tuberculosis Prevention and Control Program
San Francisco Department of Public Health
San Francisco, CA
United States